Avid Bioservices (NASDAQ:CDMO) Upgraded to “Sell” by StockNews.com
StockNews.com upgraded shares of Avid Bioservices (NASDAQ:CDMO – Free Report) to a sell rating in a report issued on Tuesday. Other research analysts also recently issued research reports about the company. Royal Bank of Canada boosted their target price on Avid Bioservices from $8.00 to $12.00 and gave the stock an outperform rating in a […]
More Stories
Security Council: Middle East envoy warns against escalation, highlights continued Israeli settlement activity
The UN envoy supporting peace efforts between Israelis and Palestinians voiced grave concern over the growing risk of widescale regional...
Blackstone Inc. (NYSE:BX) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Blackstone Inc. (NYSE:BX – Get Free Report) have been given an average recommendation of “Hold” by the nineteen...
Reserve Bank Urged to Adapt After US Fed’s Aggressive Interest Rate Reduction
By Naziya Alvi Rahman The U.S. Federal Reserve announced on Sept. 18 that it would cut interest rates by half...
Coterra Energy Inc. (NYSE:CTRA) Short Interest Update
Coterra Energy Inc. (NYSE:CTRA – Get Free Report) was the target of a significant decrease in short interest in the...
Citizens Financial Group, Inc. (NYSE:CFG) Short Interest Down 7.4% in August
Citizens Financial Group, Inc. (NYSE:CFG – Get Free Report) was the recipient of a significant decline in short interest in...
House Fails to Pass GOP Stopgap Funding Plan
By Joseph Lord, Stacy Robinson and Jackson Richman WASHINGTON—The House on Sept. 18 failed to pass a temporary spending fix...